Idera Pharmaceuticals Inc Share Price Nasdaq
Equities
US45168K3068
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | 48.62L 41Cr | Capitalization | 31.21L 26Cr |
---|---|---|---|---|---|
Net income 2021 | 9.8Cr 816.44Cr | Net income 2022 | -2.3Cr -191.61Cr | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.12% |
1st Jan change | Capi. | |
---|---|---|
+48.64% | 5.67TCr | |
-6.44% | 3.94TCr | |
+37.07% | 3.9TCr | |
+14.28% | 2.67TCr | |
-11.17% | 2.69TCr | |
-21.40% | 1.9TCr | |
+25.64% | 1.23TCr | |
+0.96% | 1.23TCr | |
+27.04% | 1.2TCr |